Patricia Schroeder is an accomplished professional with extensive experience in modeling and simulation within the pharmaceutical industry. Patricia currently serves as the Executive Director of DMPK/Modeling and Simulation at Novo Nordisk, following a distinguished tenure at Forma Therapeutics, where Patricia held multiple leadership roles including Executive Director and Senior Director of Modeling and Simulation. Previous positions include Principal Scientist in Modeling and Simulation at Biogen, Associate Director and Principal PK/PD Scientist at EMD Serono, Inc., and various scientific roles at AstraZeneca R&D Boston, culminating as Principal Scientist and Senior Scientist in PK/PD.